Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Am J Hematol
2 Ann Hematol
1 Biochem Pharmacol
2 Blood
1 BMC Cancer
1 Br J Cancer
1 Cancer
1 J Immunol
3 Leuk Lymphoma
1 Leuk Res

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Hematol

  1. BROCCOLI A, Argnani L, Nanni L, Terragna C, et al
    The treatment of hairy cell leukemia with a focus on long lasting responses to cladribine: a thirty-year experience.
    Am J Hematol. 2021 Jul 10. doi: 10.1002/ajh.26287.
    PubMed         Abstract available

    Ann Hematol

  2. MICHAELIS S, Pichler A, Stelzer I, Schoffmann L, et al
    Aggressive NK-cell leukemia with hemophagocytosis in a Caucasian patient.
    Ann Hematol. 2021 Jul 16. pii: 10.1007/s00277-021-04585.

  3. HARA R, Onizuka M, Kikkawa E, Shiraiwa S, et al
    Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ann Hematol. 2021 Jul 11. pii: 10.1007/s00277-021-04587.
    PubMed         Abstract available

    Biochem Pharmacol

  4. LU X, Yan G, Dawood M, Klauck SM, et al
    A novel moniliformin derivative as pan-inhibitor of histone deacetylases triggering apoptosis of leukemia cells.
    Biochem Pharmacol. 2021 Jul 12:114677. doi: 10.1016/j.bcp.2021.114677.
    PubMed         Abstract available


  5. NAZHA A
    Should I rock the boat? When to stop TKIs in CML.
    Blood. 2021;137:1136-1137.

    CAR-T treatment of pediatric AML: a long and winding road.
    Blood. 2021;137:1004-1006.

    BMC Cancer

  7. QIU KY, Liao XY, He ZW, Wu RH, et al
    DNA index as prognostic factor in childhood acute lymphoblastic leukemia in the COG-TARGET database.
    BMC Cancer. 2021;21:813.
    PubMed         Abstract available

    Br J Cancer

  8. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    PubMed         Abstract available


  9. KIM K, Maiti A, Loghavi S, Pourebrahim R, et al
    Outcomes of TP53-mutant acute myeloid leukemia with decitabine and venetoclax.
    Cancer. 2021 Jul 13. doi: 10.1002/cncr.33689.
    PubMed         Abstract available

    J Immunol

  10. CIAVATTONE NG, Wu L, O'Neill R, Qiu J, et al
    MyD88 Costimulation in Donor CD8(+) T Cells Enhances the Graft-versus-Tumor Effect in Murine Hematopoietic Cell Transplantation.
    J Immunol. 2021;206:892-903.
    PubMed         Abstract available

    Leuk Lymphoma

  11. BEYAN C
    Mean platelet volume may not be a predictive and prognostic marker in patients with acute myeloid leukemia.
    Leuk Lymphoma. 2021 Jul 14:1. doi: 10.1080/10428194.2021.1953017.

  12. GAO J, Fu L, Lu X, Sukhanova M, et al
    Mast cell sarcoma transdifferentiated from clonally-related T-lymphoblastic leukemia upon acquisition of TP53 mutation and genetic complexity.
    Leuk Lymphoma. 2021 Jul 14:1-4. doi: 10.1080/10428194.2021.1950710.

  13. PAGNANO KB, Peralta EH, Navarro JR, David Salas LDR, et al
    COVID-19 in chronic myeloid leukemia patients in Latin America.
    Leuk Lymphoma. 2021 Jul 13:1-7. doi: 10.1080/10428194.2021.1950709.
    PubMed         Abstract available

    Leuk Res

  14. CHENG L, Zeng S, Yan D, Tu L, et al
    Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression.
    Leuk Res. 2021;109:106649.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.